AAJ’s Seminar on Handling the Pradaxa Claim

Text Size

AAJ’s Seminar on Handling the Pradaxa Claim 

Not an AAJ Member?

Join today to have access to all of the Legal Education AAJ has to offer!

April 11, 2012
Sheraton Inner Harbor Hotel
Baltimore, MD

Search the AAJ Exchange for materials from this education program »

AAJ's Seminar on Handling the Pradaxa Claim will explain the science behind the defect and how to screen cases. Attendees will get background information on the manufacturer and ultimately how to develop your client’s case for damages in this emerging litigation. This is a must-attend seminar for trial lawyers already handling these cases as well as those considering taking these cases.
December 7, 2011: FDA issues Safety Communication
November 12, 2011: Boehringer Ingelheim confirms 260 deaths linked to Pradaxa
Pradaxa web site »

Learn about the new AAJ Pradaxa Litigation Group »

Wednesday, April 11

Screening the Case and Representing the Elderly
Brenda S. Fulmer, FL

The Science Behind the Defect
Brian D. Ketterer, MD
John M. Restaino, Jr., J.D., D.P.M., M.P.H., CO

The Benefits, Risks, and Alternatives to Warfarin
Neil “Ned” E. McWilliams, Jr., FL
The Defendant, Boehringer Ingelheim, and State Court Venues
Michelle A. Parfitt, DC

Theories of Liability and Anticipated Defenses
Mikal C. Watts, TX

History of the Warning Labels
Michael B. Lynch, FL

The Regulatory Story
Kristine K. Kraft, MO

The Foreign Experience
Ramon R. Lopez, CA

Steven D. Davis, IL

Question & Answer Panel
Moderator:  Robert K. Jenner, MD
All Faculty

The American Association for Justice
777 6th Street, NW, Ste 200 • Washington, DC  20001 • 800.424.2725 or 202.965.3500

© 2014 AAJ